<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - CanSino Biologics Ramps Up Vaccine Production During Phase III Trials
Image Overlay - CanSino Biologics Ramps Up Vaccine Production During Phase III Trials

CanSino Biologics Ramps Up Vaccine Production During Phase III Trials

September 28, 2020

CanSino Biologics Ramps Up Vaccine Production During Phase III Trials

Chinese company CanSino Biologics Inc has plans to ramp up production of their COVID-19 vaccine following the completion of Phase III clinical trials. The company plans to produce 300 million doses a year. Yourway has a 11,700 square foot local depot located in Beijing, China and has capacity globally to help facilitate clinical trials anywhere.

 Back to Index
Media

Upcoming Events

GCSG 2024 US Conference

April 21-24, 2024
Naples, Florida

Precision in Clinical Trials Summit (Boston)

May 6-7, 2024
Hilton Boston Park Plaza

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?